Liquid Chromatographic Analysis of Arabinosylcytosin and 1-β-D-Arabinofuranosyluracil in Treatment with Cyclophosphamide and Pirarubicin

A reversed-phase liquid chromatographic (RPLC) method has been developed for determination of arabinosylcytosin (Ara-C) and its metabolite 1-β-D-arabinofuranosyluracil (Ara-U) on a 250 mm × 4.6 mm i.d., 5 μm particle, Diamonsil C₁₈ column. The mobile phase was a mixture of 5% methanol and 95% 10 mmol L⁻¹ phosphate buffer adjusted to pH 5.5. The flow-rate was 1.0 mL min⁻¹ and the injection volume 20 μL. Eluting compounds were detected at 270 nm by use of an ultraviolet detector. Under these LC conditions cyclophosphamide (CTX) and pirarubicin (THP), two other medicines given with Ara-C in clinical treatment, do not interfere with measurement of Ara-C and Ara-U. Individual calibration plots of peak area against concentration generated from analysis of standard solutions were used to calculate the concentrations of Ara-C and Ara-U in sample solutions. The calibration plot was linear in the range 2.5–100 μg mL⁻¹, the average recovery of Ara-C and Ara-U was more than 98% (RSD < 2.5%), and between-day and within-day precision, expressed as relative standard deviation (RSD), were below 4.0%. LOQ for both Ara-C and Ara-U was 2 μg mL⁻¹. The method is rapid, simple, accurate and reproducible, and especially useful for application to patient samples.     

Radiation effect studies on anticancer drugs, cyclophosphamide and doxorubicin for radiation sterilization

Two anticancer drugs, cyclophosphamide (CPH) and doxorubicin hydrochloride (DOXO), in powder form were exposed to a range of doses of ⁶⁰Co gamma and electron beam radiation to study the effects of ionizing radiation. Pharmacopoeia tests, discolouration, degradation products, effect of irradiation temperature and dose rate were investigated. CPH undergoes less than 2% degradation at 30 kGy. Chromatographic studies revealed formation of several trace level degradation products, discolouration and free radicals in the irradiated CPH. N,N-bis (2-chloroethyl) group in the molecule is particularly sensitive to radiation degradation. Irradiation to 5 kGy at low temperature (77 K) did not result in significant changes. DOXO was observed to be quite radiation resistant and did not undergo significant changes in its physico-chemical properties and degradation product profile. It can be radiation sterilized at normal sterilization dose of 25 kGy.     

Microcoated wire sensors for the determination of anticancer drugs cyclophosphamide and ifosphamide in the presence of their degradates

The construction and electrochemical response characteristics of poly (vinyl chloride) and poly (vinyl chloride) carboxylate membrane sensors for the determination of cyclophosphamide and ifosphamide are described. Based on the formation of an ion-pair complex between the drug cation and sodium tetraphenylborate, two poly (vinyl chloride) sensors, namely a cyclophosphamide membrane sensor and ifosphamide membrane sensor were fabricated. They show a linear response for both drugs over the concentration range 10⁻²–10⁻⁴ M with cationic slopes of 56 and 54.6 mV per concentration decade, for sensor 1 and sensor 2, respectively. Based on the interaction between the drug solution and the dissociated COOH groups in the poly (vinyl chloride) carboxylate, sensor 3 was fabricated. It shows a linear response for both drugs over the concentration range 10⁻³–10⁻⁵ M with a cationic slope of 49.7 mV per concentration decade. The direct potentiometric determination of cyclophosphamide and ifosphamide in their pharmaceutical preparations using the proposed sensors gave average recoveries of 101.3±0.6, 100.8±10.7 and 102.0±11.0% for the sensors 1, 2 and 3, respectively, which compares reasonably well with the data obtained using the British Pharmacopoeial method (1993). Sensors 1 and 2 were also used to follow up the stability of the drugs studied in the presence of their degradates. These degradation products have no diverse effect on the responses of sensors 1 and 2.     

Sensitive detection of cyclophosphamide using DNA-modified carbon paste, pencil graphite and hanging mercury drop electrodes

The interaction of cyclophosphamide (CP) with calf thymus double-stranded DNA (dsDNA) and thermally denatured single-stranded DNA (ssDNA) immobilized at the carbon paste (CPE) and pencil graphite electrodes (PGE), was studied electrochemically based on oxidation signals of guanine and adenine using differential pulse voltammetry (DPV).As a result of the interaction of CP with DNA, the voltammetric signals of guanine and adenine increased in the case of dsDNA while a slight increase was observed in ssDNA. The effect of experimental parameters such as the interaction time between CP and DNA forms and the concentration of CP, were studied using DPV with CPE and PGE. Additionally, reproducibility and detection limits were determined using both electrodes. A comparison of the analytical performance between CPE and PGE was done. Our results showed that these two different DNA biosensors could be used for the sensitive, rapid and cost effective detection of CP itself as well as of CP-DNA interaction.Furthermore, the interaction of CP with dsDNA and ssDNA was studied in solution and at the electrode surface by means of alternating current voltammetry (ACV) in 0.3 M NaCl and 50 mM sodium phosphate buffer (pH 8.5) supporting electrolyte, using a hanging mercury drop electrode (HMDE) as working electrode.The conclusions of this study were mainly based on tensammetric peaks I (at −1.183 V) and II (−1.419 V) of DNA. This study involved the interaction of CP with surface-confined and solution phase DNA where experimental parameters, such as the concentration of CP and the interaction time, were studied. By increasing the concentration of CP, an increase of peak II was observed in both ds and ssDNA, while an increase of peak I was observed only in the case of dsDNA. An overall conclusion of the study using HMDE was that the interaction of CP with surface-confined DNA significantly differed from that with solution phase DNA. The increase of peaks I and II was lower in the case of interaction of CP with surface-confined DNA, probably due to steric positioning of DNA at the electrode surface.     

Spectrophotometric and Spectrofluorimetric Determination of Cyclophosphamide and Its Isomer Ifosphamide

Abstract

Based on the condensation reaction between amino groups of either cyclophosphamide or ifosphamide with the carbonyl group of ninhydrin, giving coloured and fluorescent products, a spectrophotometric procedure for both drugs is suggested in the range from 30 to 90μg ml^?1 at 564 nm, with accuracies of 100.6 ± 1.06% and 100.8 ± 1.02% for cyclophosphamide and ifosphamide, respectively. Also, a spectrophotometric procedure for both drugs is proposed in the range from 1.2 to 3.6 μg ml^?1 at 465 nm and 485 nm for cyclophosphamide and ifosphamide, respectively, using 380 nm as an excitation wavelength for both drugs with accuracies of 100.4 ± 1.83% and 99.5 ± 1.64%, respectively. This condensation reaction, however, does not differentiate between the two isomeric drugs.

Another new method is, therefore, suggested. It depends on the fact that the secondary amino group of ifosphamide is hindered electronically and sterically, while the nucleophilic amino group of cyclophosphamide reacts with the nitrosyl group of sodium nitroprusside molecule, giving a bluish green colour measurable at 708 nm. This colour is used for the determination of cyclophospahmide in the presence of its isomer ifophamide in the range from 0.2 to 1 mg ml^?1 with repeatability of 99.2 ± 1.49%.

The suggested procedures are applied successfully to pharmaceutical formulations of cyclophosphamide and ifosphamide, and their validities are assessed by applying the standard addition technique. The results obtained by applying the proposed procedures are statistically analyzed and compared with those obtained by adopting the United States Pharmacopoeial method.     

Controlled release of 4-hydroperoxycyclophosphamide from the fatty acid dimer-sebacic acid copolymer

Controlled polymeric release of chemotherapeutic agents has shown promise in the management of malignant gliomas. 4-Hydroperoxycyclophosphamide (4HC), loaded on the fatty acid dimer–sebacic acid copolymer (FAD:SA, 1:1), significantly prolonged survival in rats implanted with F98 and 9L gliomas. Here, we studied the in vitro and in vivo release kinetics in phosphate-buffered saline and rat brain of 20% 4HC/FAD:SA (wt:wt), the optimal dose for treatment of rat gliomas. In vitro release under infinite sink conditions was steady over the initial 12 hr to a peak of 20–35% of impregnated drug, consistent with early phase control via surface erosion. Release over the next 3 weeks was minimal, consistent with barrier formation around the polymer by an oily fatty acid dimer degradation product and consequent slowing of release. However, the polymer started to disintegrate by day 4, and there were minimal visible remnants by 3 weeks. Thus, a considerable amount of polymer-carried drug was probably lost in the disintegrating fragments. Also, drug loss is expected from its inherent hydrolytic instability. In vivo release into brain revealed two peak levels of drug at 0–1 hr and 5–20 days. With loaded polymer implanted intraperitoneally or cyclophosphamide injected systemically, peak brain drug levels were measured in 2–8 hr, with substantial decrease by 48 hr without a second peak. Brain levels were substantially higher than blood levels at all time periods. We conclude that FAD:SA (1:1) adequately protects the otherwise labile 4HC, allowing effective and substained drug release in vivo. Furthermore, it should be possible to modify the polymer to adjust the time of peak release for more beneficial therapeutic effects.     

Quantitative analysis of methadone in human urine samples by microextraction in packed syringe-gas chromatography-mass spectrometry (MEPS-GC-MS)

A method for the simultaneous analysis of methadone in urine samples by microextraction in a packed syringe online with GC-MS (MEPS-GC-MS) is described. The new method reduced the sample handling and the detection limit by two- to seven-fold compared to published methods. Using a quantitation method based on the calculation of analyte concentration by comparison to an internal standard, we were able to measure methadone levels consistent with values reported for healthy individuals. The intra-assay precisions (RSD) of the method using quality control (QC) samples at three different concentration levels were about 11-14% (n = 6). The interassay precisions (RSD) were 11-15% for methadone in urine samples (n = 18). The accuracy varied from 89 to 109% for intra-assay (n = 6), and 97 to 107% for inter-assay (n = 18). The regression correlation coefficients (r(2)) were over 0.99 in all experiments.     

Synthesis and epimerization of phenylalanyl 4-aminocyclophosphamides

Peptide and amino acid conjugates of (4R)- and (4S)-4-aminocyclophosphamides (4-NH₂-CPA, 3) were designed as prodrug forms of phosphoramide mustard. Four diastereomers of Boc-Phe-4-NH-CPA (6) were synthesized stereospecifically from homoserine (R or S) and the protection strategy was optimized for the homoserine hydroxyl group during the construction of the 1,3,2-oxazaphosphorinane ring. The Phe-4-NH-CPA isomers of the trans-configuration ((2S,4R)- and (2R,4S)-) were found to be less stable than the corresponding isomers of the cis-configuration ((2R,4R)- and (2S,4S)-) and to undergo epimerization of the C-4 chiral center in the presence of 25% TFA used during Boc deprotection. The synthetic route developed should be applicable to the synthesis of a variety of peptide and amino acid conjugates of 4-aminocyclophosphamide.     

Determination of cyclophosphamide and ifosfamide in sewage effluent by stable isotope-dilution liquid chromatography-tandem mass spectrometry

A reliable and specific method was developed for the determination of the cytotoxic drugs cyclophosphamide and ifosfamide in sewage effluent. The most successful combination was found to be Strata-X solid-phase extraction followed by Florisil^® clean-up with analysis by liquid chromatography–tandem mass spectrometry. Quantification by internal standardisation was achieved using custom synthesised d4-cyclophophosphamide. The mass spectrometer was operated in highly selective reaction monitoring (HSRM) mode, which significantly reduced matrix noise and improved sensitivity. Although it suffered from some ionisation suppression, electrospray ionisation (ESI) was found to give an order of magnitude better sensitivity in terms of limit of detection than atmospheric pressure chemical ionisation (APCI). Using final effluent from two different sewage treatment plants, the method was validated following official European guidelines and shown to be a high performance tool for routine analysis at the sub-nanogram per litre level. Depending on the matrix, the limit of detection for cyclophosphamide was between 0.03 ng/L and 0.12 ng/L and for ifosfamide between 0.05 ng/L and 0.09 ng/L. For cyclophosphamide the accuracy and precision, tested at 1.7 ng/L, were 98–109% and ≤13%, CV respectively. For ifosfamide the accuracy and precision, tested at 1.1 ng/L, were 98–113% and ≤15% CV, respectively. Depending on the sample matrix the absolute recovery of the internal standard was between 57% and 70%. The method was tested by analysis of spot samples taken from the final effluent discharges of two sewage treatment plants; the first using a conventional trickling filter treatment process and second employing activated sludge followed by ultra violet treatment. Cyclophosphamide was detected at 0.19 ng/L at the first plant and at the second detected at 3.7 ng/L and 3.5 ng/L, before and after the UV treatment process; ifosfamide was not detectable at either plant.     

The autoderivatization of 4-ketocyclophosphamide during capillary gas chromatography

The selectivity of a capillary gas chromatographic assay for the anti-neoplastic and immunosuppressive agent cyclophosphamide (CPA) towards one of its naturally occurring metabolites, i.e. 4-ketocyclophosphamide (4-keto CPA), has been studied. Mass spectrometry studies showed that a cyclization product of 4-keto-CPA can form using the same chromatographic conditions as those under which CPA was determined. However, the amount produced is relatively small (less than 10%) compared with the percentage produced from CPA. Furthermore, both cyclization products, formed by loss of HCI and intraalkylation of the parent compounds, can be separated well under suitable chromatographic conditions.